BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 5075259)

  • 1. The determination of isoniazid and its metabolites acetylisoniazid, monoacetylhydrazine, diacetylhydrazine, isonicotinic acid and isonicotinylglycine in serum and urine.
    Ellard GA; Gammon PT; Wallace SM
    Biochem J; 1972 Feb; 126(3):449-58. PubMed ID: 5075259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-performance liquid chromatographic determination of isoniazid, acetylisoniazid and hydrazine in biological fluids.
    Seifart HI; Gent WL; Parkin DP; van Jaarsveld PP; Donald PR
    J Chromatogr B Biomed Appl; 1995 Dec; 674(2):269-75. PubMed ID: 8788156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of isoniazid, acetylisoniazid, acetylhydrazine and diacetylhydrazine in biological fluids by high-performance liquid chromatography.
    von Sassen W; Castro-Parra M; Musch E; Eichelbaum M
    J Chromatogr; 1985 Feb; 338(1):113-22. PubMed ID: 4019638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorometric determination of isoniazid and its metabolites in urine by high-performance liquid chromatography using in-line derivatization.
    Kohno H; Kubo H; Furukawa K; Yoshino N; Nishikawa T
    Ther Drug Monit; 1991 Sep; 13(5):428-32. PubMed ID: 1957336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of hydrazine metabolites of isoniazid in human urine by gas chromatography.
    Timbrell JA; Wright JM; Smith CM
    J Chromatogr; 1977 Aug; 138(1):165-72. PubMed ID: 893592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of isoniazid and metabolites in biological fluids.
    Boxenbaum HG; Riegelman S
    J Pharm Sci; 1974 Aug; 63(8):1191-7. PubMed ID: 4851320
    [No Abstract]   [Full Text] [Related]  

  • 7. Determination of the acetylator phenotype from the ratio of the urinary excretion of acetylisoniazid to acid-labile isoniazid: a study in Finnish Lapland.
    Ellard GA; Gammon PT; Tiitinen H
    Tubercle; 1973 Sep; 54(3):201-10. PubMed ID: 4773075
    [No Abstract]   [Full Text] [Related]  

  • 8. Comprehensive assay for pyrazinamide, rifampicin and isoniazid with its hydrazine metabolites in human plasma by column liquid chromatography.
    Walubo A; Smith P; Folb PI
    J Chromatogr B Biomed Appl; 1994 Aug; 658(2):391-6. PubMed ID: 7820269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple method for determining isoniazid acetylator phenotype.
    Russell DW
    Br Med J; 1970 Aug; 3(5718):324-5. PubMed ID: 5451955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of the potential use of isoniazid, acetylisoniazid and isonicotinic acid for monitoring the self-administration of drugs.
    Ellard GA; Jenner PJ; Downs PA
    Br J Clin Pharmacol; 1980 Oct; 10(4):369-81. PubMed ID: 7448108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoacetylhydrazine as a metabolite of isoniazid in man.
    Timbrell JA; Wright JM; Baillie TA
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):602-8. PubMed ID: 913027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sensitive urine-test method for monitoring the ingestion of isoniazid.
    Ellard GA; Greenfield
    J Clin Pathol; 1977 Jan; 30(1):84-7. PubMed ID: 838875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of isonicotinic acid in the presence of isoniazid and acetylisoniazid. Studies on isonicotinic acid formation from isoniazid in isolated rat hepatocytes.
    Ono Y; Noda A; Zaima Y; Jitsufuchi N; Eto S; Noda H
    J Chromatogr B Biomed Appl; 1996 Mar; 677(2):339-43. PubMed ID: 8704939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental studies on the isoniazid (INH) therapy. I. Separation and determination of INH and its metabolites in body fluids using ion exchange resins].
    Okudaira M; Kuchii M; Hasaki K
    Iryo; 1969 Oct; 23(10):1283-90. PubMed ID: 5364979
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of the toxic hydrazino metabolites formed from isoniazid in humans.
    Lauterburg BH; Smith CV; Todd EL; Mitchell JR
    J Pharmacol Exp Ther; 1985 Dec; 235(3):566-70. PubMed ID: 4078724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic evaluation of aconiazide, a potentially less toxic isoniazid prodrug.
    Peloquin CA; James GT; Craig LD; Kim M; McCarthy EA; Iklé D; Iseman MD
    Pharmacotherapy; 1994; 14(4):415-23. PubMed ID: 7937278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidation of hydrazine metabolites formed from isoniazid.
    Lauterburg BH; Smith CV; Todd EL; Mitchell JR
    Clin Pharmacol Ther; 1985 Nov; 38(5):566-71. PubMed ID: 3931954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotoxicity of isoniazid and its metabolites in cultures of mouse dorsal root ganglion neurons and hybrid neuronal cell line.
    Sanfeliu C; Wright JM; Kim SU
    Neurotoxicology; 1999 Dec; 20(6):935-44. PubMed ID: 10693974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of oxygen free radicals in isoniazid-induced hepatotoxicity.
    Walubo A; Smith P; Folb PI
    Methods Find Exp Clin Pharmacol; 1998 Oct; 20(8):649-55. PubMed ID: 9922980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of rifampin, phenobarbital pretreatment, and acetylator phenotype on acetylisoniazid metabolism in the rabbit.
    Thomas BH; Zeitz W; Whitehouse LW
    Can J Physiol Pharmacol; 1987 Mar; 65(3):419-23. PubMed ID: 3580961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.